Drug efficacy evaluation

No. AR PL HD Year Citation Title 1st author
30 X 2017 Thromb Res 153,p76-82(2017) Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment V Taune
26 X X 2016 J Clin Med Res 8(12),p899-907(2016) Evaluation of the antithrombotic effects of Rivaroxaban and Apixaban using the Total Thrombus-formation Analysis System : in vitro and ex vivo studies H Sugihara
24 X X 2016 Thromb Haemost 117(01),p75-85(2017) Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system A Ågren
25 X 2016 Thromb Res 146,p69-75(2016) Plasminogen activator inhibitor type 1 in platelets induces thrombogenicity by increasing thrombolysis resistance under shear stress in an in-vitro flow chamber model K Hosokawa
23 X X 2016 Heart Vessels 32,p309-316(2017) Evaluation of the antithrombotic abilities of non-vitamin K antagonist oral anticoagulants using the Total Thrombus-formation Analysis System Y Idemoto
22 X 2016 J Thromb and Haemost 14,p1-10(2016) Measurement of residual platelet thrombogenicity under arterial shear conditions in cerebrovascular disease patients receiving antiplatelet therapy M Yamazaki
17 X 2015 J Thromb Haemost 13,p1-10(2016) Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy Y Arima
15 X X 2015 Int J Cardiol 197,p98-100(2015) A novel quantitative assessment of whole blood thrombogenicity in patients treated with a non-vitamin K oral anticoagulant D Sueta
12 X 2013 PLoS One 9(1):e86491 (2014) Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model. K Hosokawa
11 X X 2013 J Cardiothorac Vasc Anesth 27(6),e69–e84(2013) Influences of Hemodilution and anticoagulation on antiplatelet P2Y12 therapy: in vitro whole blood perfusion model. S Ogawa
10 X 2013 Thromb Res 133(1),p66-72,(2014) Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions. K Hosokawa
9 X 2013 Br J Anaesth 111(6),p1013-1023(2013) Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions. S Ogawa
6 X 2012 Thromb Haemost 109(01),p102-111(2013) Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions. K Hosokawa
3 X 2011 Microvasc Res 83,p154-161(2012) A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process. K Hosokawa
2 X 2011 Thromb Haemost 106(6),p1215-1223(2011) A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions. S Ogawa
1 X 2011 J Thromb Haemost 9(10),p2029-2037(2011) A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions. K Hosokawa
PL Chip for T-TAS01 is available for in vitro diagnostic use only in the the United States and EU Copyright © 2021 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.